Brigitte Mlineritsch Selected Research

Aminoglutethimide (Cytadren)

12/2007	Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
3/2003	Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brigitte Mlineritsch Research Topics

Disease

29	Breast Neoplasms (Breast Cancer) 01/2019 - 12/2002
14	Neoplasms (Cancer) 01/2019 - 12/2002
12	Colorectal Neoplasms (Colorectal Cancer) 03/2014 - 12/2002
2	Pathologic Complete Response 01/2019 - 05/2007
2	Osteoporosis 01/2019 - 08/2015
2	Disease Progression 11/2018 - 02/2009
2	Arthralgia (Joint Pain) 08/2015 - 07/2011
2	Neoplasm Metastasis (Metastasis) 05/2009 - 12/2007
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Adenocarcinoma 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Renal Insufficiency (Renal Failure) 01/2019
1	Cataract (Cataracts) 01/2019
1	Osteoarthritis 01/2019
1	Multiple Myeloma 11/2018
1	Triple Negative Breast Neoplasms 11/2018
1	Lung Neoplasms (Lung Cancer) 11/2018
1	Frailty 01/2016
1	Ovarian Neoplasms (Ovarian Cancer) 01/2016
1	Metabolic Bone Diseases (Osteopenia) 08/2015
1	Brain Neoplasms (Brain Tumor) 01/2015
1	Sarcoma (Soft Tissue Sarcoma) 08/2014
1	Leiomyosarcoma 08/2014
1	Hypertension (High Blood Pressure) 01/2014
1	Overweight 07/2011
1	Headache (Headaches) 07/2011
1	Fatigue 07/2011
1	Pain (Aches) 07/2011
1	Bone Diseases (Bone Disease) 03/2011
1	Bone Resorption 03/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2011
1	Anemia 04/2008
1	Amyloidosis 11/2004
1	Thrombocytosis (Thrombocythemia) 06/2003
1	Lymphoma (Lymphomas) 09/2002

Drug/Important Bio-Agent (IBA)

14	Hormones (Hormone)IBA 01/2019 - 12/2002
9	Tamoxifen FDA LinkGeneric 03/2012 - 12/2002
7	Anastrozole (Arimidex)FDA LinkGeneric 03/2012 - 03/2007
6	Aromatase InhibitorsIBA 01/2019 - 12/2007
6	Goserelin (Zoladex)FDA Link 07/2011 - 12/2002
6	Zoledronic Acid (Zometa)FDA Link 07/2011 - 03/2007
3	Pharmaceutical PreparationsIBA 08/2015 - 11/2007
3	liposomal doxorubicin (Doxil)FDA Link 01/2015 - 02/2009
2	Denosumab FDA Link 01/2019 - 08/2015
2	Estrogen ReceptorsIBA 12/2018 - 03/2012
2	1-dodecylpyridoxal (PLD)IBA 01/2015 - 08/2011
2	Sorafenib (BAY 43-9006)FDA Link 08/2014 - 01/2011
2	Fulvestrant (Faslodex)FDA Link 05/2009 - 11/2007
2	Methotrexate (Mexate)FDA LinkGeneric 04/2008 - 12/2002
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2008 - 12/2002
2	Fluorouracil (Carac)FDA LinkGeneric 04/2008 - 12/2002
2	Aminoglutethimide (Cytadren)FDA Link 12/2007 - 03/2003
1	130-nm albumin-bound paclitaxelIBA 01/2021
1	Gemcitabine FDA Link 01/2021
1	ixazomibIBA 11/2018
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2018
1	Carboplatin (JM8)FDA LinkGeneric 11/2018
1	Bortezomib (Velcade)FDA Link 11/2018
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Immune Checkpoint InhibitorsIBA 01/2016
1	AntibodiesIBA 01/2016
1	RANK LigandIBA 08/2015
1	Lapatinib (GW572016)FDA Link 01/2015
1	Trastuzumab (Herceptin)FDA Link 01/2015
1	ParaffinIBA 03/2014
1	Formaldehyde (Formol)FDA Link 03/2014
1	Bevacizumab (Avastin)FDA Link 01/2014
1	EnzymesIBA 07/2011
1	Aromatase (CYP19)IBA 07/2011
1	NitrogenIBA 03/2011
1	Diphosphonates (Bisphosphonates)IBA 03/2011
1	Mevalonic Acid (Mevalonate)IBA 03/2011
1	Everolimus FDA Link 01/2011
1	Sunitinib (Sutent)FDA Link 01/2011
1	TOR Serine-Threonine KinasesIBA 01/2011
1	temsirolimus FDA Link 01/2011
1	Progesterone Receptors (Progesterone Receptor)IBA 05/2009
1	thiamine triphosphorate (TTP)IBA 05/2009
1	Estrogens (Estrogen)FDA Link 02/2009
1	Vinorelbine (Navelbine)FDA LinkGeneric 02/2009
1	exemestane (Aromasin)FDA Link 11/2008
1	Hemoglobins (Hemoglobin)IBA 04/2008
1	Letrozole (Femara)FDA LinkGeneric 12/2007
1	Epirubicin (Ellence)FDA LinkGeneric 05/2007
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2007
1	Docetaxel (Taxotere)FDA Link 05/2007
1	SteroidsIBA 12/2002
1	Cladribine FDA LinkGeneric 09/2002

Therapy/Procedure

16	Therapeutics 01/2019 - 11/2004
7	Drug Therapy (Chemotherapy) 01/2019 - 09/2002
4	Adjuvant Chemotherapy 11/2016 - 01/2009
3	Neoadjuvant Therapy 01/2019 - 05/2007
2	Combination Drug Therapy (Combination Chemotherapy) 01/2009 - 04/2008
2	Segmental Mastectomy (Lumpectomy) 04/2008 - 05/2007
2	Mastectomy (Mammectomy) 04/2008 - 04/2003
1	Radiotherapy 01/2019
1	Time-to-Treatment 08/2014
1	CMF regimen 04/2008
1	Duration of Therapy 03/2007
1	Ovariectomy (Oophorectomy) 12/2002